EBOS Group Limited (EBO.NZ)

UPDATE 3-NZ's EBOS not to proceed with $2.44 billion Greencross acquisition

Australasian pharmaceutical manufacturer EBOS Group said on Wednesday it would not proceed with a potential major transaction in the animal care segment, sending its shares 7% lower. The statement did not name its takeover target but a source with direct knowledge of the matter had said the company was in talks to acquire TPG Capital-backed pets and vets business Greencross. The Australian Financial Review reported that EBOS would pay A$3.75 billion ($2.44 billion) to acquire Greencross, without citing sources, and were set to raise about A$2 billion as early as Wednesday.